Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

596
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
596
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

315
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
315
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

2.5K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.5K
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants

1.4K

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.4K
Cholinergic Neurons: Neurotransmission01:23

Cholinergic Neurons: Neurotransmission

3.1K
Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
3.1K
Cholinergic Receptors: Nicotinic01:15

Cholinergic Receptors: Nicotinic

3.0K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Region-specific regulation of glucocorticoid and mineralocorticoid receptor signaling in a mouse model of oral contraceptive exposure.

bioRxiv : the preprint server for biology·2026
Same author

Twenty years of sex and gender science in health research: a policy statement from the Organization for the Study of Sex Differences.

Biology of sex differences·2026
Same author

Cortico-striatal action control inherent of opponent cognitive-motivational styles.

eLife·2025
Same author

Beyond Birth Control: The Neuroscience of Hormonal Contraceptives.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2024
Same author

Quantifying social roles in multi-animal videos using subject-aware deep-learning.

bioRxiv : the preprint server for biology·2024
Same author

Cortico-striatal action control inherent of opponent cognitive-motivational styles.

bioRxiv : the preprint server for biology·2024

Related Experiment Video

Updated: Aug 9, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.3K

Neuro-Immune Modulation of Cholinergic Signaling in an Addiction Vulnerability Trait.

Hanna Carmon1, Evan C Haley2, Vinay Parikh2

  • 1Department of Psychology, University of Michigan, Ann Arbor, MI 48109.

Eneuro
|February 22, 2023
PubMed
Summary

Sign-tracking rats exhibit higher ubiquitinated choline transporters (CHTs) and brain cytokines, linked to addiction vulnerability. Immune activation reveals phenotype-specific CHT regulation, highlighting brain immune signaling

Keywords:
acetylcholinecholine transportercytokineslipopolysaccharidepoly-ubiquitinationsubstance use disorder

More Related Videos

Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior
10:05

Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior

Published on: September 16, 2015

14.4K
BS3 Chemical Crosslinking Assay: Evaluating the Effect of Chronic Stress on Cell Surface GABAA Receptor Presentation in the Rodent Brain
05:17

BS3 Chemical Crosslinking Assay: Evaluating the Effect of Chronic Stress on Cell Surface GABAA Receptor Presentation in the Rodent Brain

Published on: May 26, 2023

1.3K

Related Experiment Videos

Last Updated: Aug 9, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.3K
Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior
10:05

Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior

Published on: September 16, 2015

14.4K
BS3 Chemical Crosslinking Assay: Evaluating the Effect of Chronic Stress on Cell Surface GABAA Receptor Presentation in the Rodent Brain
05:17

BS3 Chemical Crosslinking Assay: Evaluating the Effect of Chronic Stress on Cell Surface GABAA Receptor Presentation in the Rodent Brain

Published on: May 26, 2023

1.3K

Area of Science:

  • Neuroscience
  • Behavioral Neuroscience
  • Psychology

Background:

  • Sign-tracking (ST) is characterized by approaching reward cues, unlike goal-tracking (GT).
  • ST behavior is associated with attentional deficits and addiction vulnerability.
  • Previous research linked ST attentional deficits to reduced cholinergic signaling via choline transporters (CHTs).

Purpose of the Study:

  • To investigate the role of CHT poly-ubiquitination in sign-tracking behavior.
  • To test the hypothesis that elevated cytokine signaling contributes to CHT modification in STs.
  • To explore the impact of immune system activation on CHTs and cytokines in ST and GT rats.

Main Methods:

  • Compared ubiquitination levels of intracellular and plasma membrane CHTs in ST and GT rats.
  • Measured cytokine levels in brain regions (cortex, striatum) and spleen of ST and GT rats.
  • Administered lipopolysaccharide (LPS) to assess immune system activation effects on CHTs and cytokines.

Main Results:

  • Intracellular CHTs were highly ubiquitinated in ST rats compared to GT rats.
  • ST rats showed higher cytokine levels in the cortex and striatum than GT rats.
  • LPS administration elevated ubiquitinated CHTs in GTs but not STs, suggesting ceiling effects in STs.

Conclusions:

  • Elevated brain cytokine signaling in ST rats is associated with increased CHT poly-ubiquitination.
  • These findings suggest a link between immune system modulation and CHT regulation in addiction vulnerability.
  • Interactions between brain immune signaling and CHT regulation are crucial for the neural basis of sign-tracking behavior.